Search research articles
Contact Us
Filters
Showing results (441-450 of 560) with videos related to
Page
of 56
Sort By:
International Journal of Molecular Sciences
|
September 14, 2024
A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients
Domenico Mallardo, Mario Fordellone, Andrew White, et al.
Journal of Translational Medicine
|
September 8, 2023
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy
Domenico Mallardo, Mario Fordellone, Andrew White, et al.
American Journal of Clinical Pathology
|
October 6, 2005
Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases
Robert P Gormley, Rashna Madan, Alina E Dulau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2022
Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification
D Trapani, M A Franzoi, H J Burstein, et al.
Therapeutic Advances in Medical Oncology
|
March 26, 2021
Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy
Morena Fasano, Carminia Maria Della Corte, Giuseppe Viscardi, et al.
Cancer
|
November 2, 2021
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse events
Edward H Ip, Santiago Saldana, Kathy D Miller, et al.
Breast Cancer Research and Treatment
|
June 7, 2014
A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer
Yifan Tu, Dawn L Hershman, Kapil Bhalla, et al.
Cancer Immunology, Immunotherapy : CII
|
June 8, 2024
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma
Domenico Mallardo, Francesca Sparano, Maria Grazia Vitale, et al.
Andrology
|
April 6, 2026
Living Together, Loving Apart: Health, Sexuality and Relationships in Middle-Aged and Older Men in Europe
Clotilde Sparano, Giammarco Alderotti, Giulia Rastrelli, et al.
Breast Cancer Research and Treatment
|
June 25, 2021
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
Matthew Kearney, Lauren Franks, Shing Lee, et al.
Page
of 56
Search research articles
Search
Showing results (441-450 of 560) with videos related to
Sort By:
Page
of 56
International Journal of Molecular Sciences
|
September 14, 2024
A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients
Domenico Mallardo, Mario Fordellone, Andrew White, et al.
Journal of Translational Medicine
|
September 8, 2023
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy
Domenico Mallardo, Mario Fordellone, Andrew White, et al.
American Journal of Clinical Pathology
|
October 6, 2005
Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases
Robert P Gormley, Rashna Madan, Alina E Dulau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2022
Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification
D Trapani, M A Franzoi, H J Burstein, et al.
Therapeutic Advances in Medical Oncology
|
March 26, 2021
Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy
Morena Fasano, Carminia Maria Della Corte, Giuseppe Viscardi, et al.
Cancer
|
November 2, 2021
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse events
Edward H Ip, Santiago Saldana, Kathy D Miller, et al.
Breast Cancer Research and Treatment
|
June 7, 2014
A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer
Yifan Tu, Dawn L Hershman, Kapil Bhalla, et al.
Cancer Immunology, Immunotherapy : CII
|
June 8, 2024
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma
Domenico Mallardo, Francesca Sparano, Maria Grazia Vitale, et al.
Andrology
|
April 6, 2026
Living Together, Loving Apart: Health, Sexuality and Relationships in Middle-Aged and Older Men in Europe
Clotilde Sparano, Giammarco Alderotti, Giulia Rastrelli, et al.
Breast Cancer Research and Treatment
|
June 25, 2021
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
Matthew Kearney, Lauren Franks, Shing Lee, et al.
Page
of 56